Rhenman & Partners Asset Management Ab Annexon, Inc. Transaction History

Rhenman & Partners Asset Management Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $527,500 - $1.01 Million	-250,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.81 - $27.48 $1.25 Million - $1.92 Million	70,000 Added 38.89%	250,000 $5.63 Million
Q1 2021 May 14, 2021	BUY	$22.0 - $35.01 $1.1 Million - $1.75 Million	50,000 Added 38.46%	180,000 $5.01 Million
Q4 2020 Jan 19, 2021	BUY	$20.81 - $30.55 $2.71 Million - $3.97 Million	130,000 New	130,000 $3.25 Million

138

87.3M

2.54M

556K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $218M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.